amifostine anhydrous has been researched along with Cancer of Pancreas in 4 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Unresectable pancreatic cancer is almost universally lethal because chemotherapy and radiation cannot completely stop the growth of the cancer." | 1.51 | Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation. ( Chan, WK; Dantzer, R; de la Cruz Bonilla, M; Deorukhkar, A; Fujimoto, TN; Garcia, CJG; Grossberg, AJ; Horvath, TD; Lin, D; Lorenzi, PL; Mason, KA; Molkentine, JM; Piwnica-Worms, H; Samuel, ELG; Taniguchi, CM; Tour, JM, 2019) |
| "Transient hypotension was the most common side effect occurring in association with amifostine." | 1.31 | Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study. ( Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molkentine, JM | 1 |
| Fujimoto, TN | 1 |
| Horvath, TD | 1 |
| Grossberg, AJ | 1 |
| Garcia, CJG | 1 |
| Deorukhkar, A | 1 |
| de la Cruz Bonilla, M | 1 |
| Lin, D | 1 |
| Samuel, ELG | 1 |
| Chan, WK | 1 |
| Lorenzi, PL | 1 |
| Piwnica-Worms, H | 1 |
| Dantzer, R | 1 |
| Tour, JM | 1 |
| Mason, KA | 1 |
| Taniguchi, CM | 1 |
| Genvresse, I | 1 |
| Lange, C | 1 |
| Schanz, J | 1 |
| Schweigert, M | 1 |
| Harder, H | 1 |
| Possinger, K | 1 |
| Späth-Schwalbe, E | 1 |
| Yavuz, AA | 1 |
| Aydin, F | 1 |
| Yavuz, MN | 1 |
| Ilis, E | 1 |
| Ozdemir, F | 1 |
| Halberg, FE | 1 |
| LaRue, SM | 1 |
| Rayner, AA | 1 |
| Burnel, WM | 1 |
| Powers, BE | 1 |
| Chan, AS | 1 |
| Schell, MC | 1 |
| Gillette, EL | 1 |
| Phillips, TL | 1 |
1 trial available for amifostine anhydrous and Cancer of Pancreas
| Article | Year |
|---|---|
Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Amifostine; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Pro | 2001 |
3 other studies available for amifostine anhydrous and Cancer of Pancreas
| Article | Year |
|---|---|
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation.
Topics: Administration, Oral; Amifostine; Animals; Female; Intestine, Small; Male; Mercaptoethylamines; Mice | 2019 |
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation.
Topics: Administration, Oral; Amifostine; Animals; Female; Intestine, Small; Male; Mercaptoethylamines; Mice | 2019 |
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation.
Topics: Administration, Oral; Amifostine; Animals; Female; Intestine, Small; Male; Mercaptoethylamines; Mice | 2019 |
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated Radiation.
Topics: Administration, Oral; Amifostine; Animals; Female; Intestine, Small; Male; Mercaptoethylamines; Mice | 2019 |
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Com | 2001 |
Intraoperative radiotherapy with localized radioprotection: diminished duodenal toxicity with intraluminal WR2721.
Topics: Amifostine; Animals; Dogs; Duodenum; Female; Male; Pancreatic Neoplasms | 1991 |